Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
Tweet Send to a Friend
Piper Jaffray & Co. downgrades Phase Forward (Nasdaq: PFWD) from Buy to Neutral.
Piper analyst says, "GlaxoSmithKline (NYSE: GSK) signed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper analyst says, "GlaxoSmithKline (NYSE: GSK) signed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
